Monthly Archives: July 2012

DTC Genomics Profitable?

Maybe there is hope that 23andMe, as well as the other DTC genomics companies can make a living in the end: http://www.bio-itworld.com/els/2012/05/29/23andme-announces-first-patent.html Although, it is not clear how useful this particular patent will be.  More detailed discussion here: http://www.genomicslawreport.com/index.php/2012/06/01/patenting-and-personal-genomics-23andme-receives-its-first-patent-and-plenty-of-questions/






Posted in DTC Genetic Testing, genomics, personalized medicine | Tagged , , | Comments Off on DTC Genomics Profitable?